Intrarectal Dehydroleucodine Suppresses Trinitrobenzene Sulfonic Acid–Induced Colitis in Rats, A Model for Inflammatory Bowel Disease

References

• Ardite E, Panes J, Miranda M, Salas A, Elizalde JI, Sans M, Arce Y, Bordas JM, Fernández-Checa JC, Pique JM (1998): Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease. Br J Pharmacol 124: 4311–4313.
   Web of Science ®Google Scholar
• Ariza Espinar L, Bonzani N (1992): El mático de la región de Cuyo (Argentina). Acta Farm Bonaerense 11: 39–145.
   Google Scholar
• Bork PM, Lienhard Schmitz M, Kuhnt M, Escher C, Heinrich M (1997): Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB. FEBS Lett 402: 85–90.
   PubMed Web of Science ®Google Scholar
• Conner EM, Brand S, Grisham MB (1998): Inhibition of chronic granulomatous colitis by a selective proteasome inhibitor: Antagonist of nuclear transcription factor KB (NF-κB) activation. Br J Pharmacol 124: 431–433.
   PubMedGoogle Scholar
• Fries W, Pagiaro E, Canova E, Carraro P, Gasparini G, Pomerri F, Martin A, Carlotto C, Mazzon E, Sturniolo G, Longo G (1998): The effect of heparin on trinitrobenzene sulfonic acid induced colitis in the rat. Aliment Pharmacol Ther 12: 229–236.
   PubMed Web of Science ®Google Scholar
• Giordano OS, Guerreiro E, Pestchanker MJ, Guzmán JA, Pastor D, Guardia T (1990): The gastric citoprotective effect of several sesquiterpene lactones. J Nat Prod 53: 803–809.
   PubMed Web of Science ®Google Scholar
• Grisham MB, Volkmer C, Tso P, Yamada T (1991): Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101: 540–547.
   PubMed Web of Science ®Google Scholar
• Guardia T, Guzmán JA, Pestchanker M, Guerreiro E, Giordano O (1994): Mucus synthesis and sulfhidryle groups in cytoprotection mediates by dehydroleucodine, a sesquiterpene lactone. J Nat Prod 57: 507–509.
   PubMed Web of Science ®Google Scholar
• Guardia T, Juárez AO, Guerreiro E, Guzmán JA, Pelzer LE (2003): Anti-inflammatory activity and effect on gastric secretion of dehydroleucodine isolated from Artemisia douglasiana.. J Ethnopharmacol 88: 195–198.
   PubMed Web of Science ®Google Scholar
• Hall IH, Lee KH, Starnes CO, Sumida Y, Wu RY, Waddell TG, Cochran JW, Gerhart KG (1979): Anti-inflammatory activity of sesquiterpene lactones and related compounds. J Pharm Sci 68: 537–541.
   PubMed Web of Science ®Google Scholar
• Hall IH, Starnes CO, Lee KH, Waddell TG (1980): Mode of action of sesquiterpene lactones as anti-inflammatory agents. J Pharm Sci 69: 537–543.
   PubMed Web of Science ®Google Scholar
• Halm D, Halm ST (2000): Secretagogue response of goblet cells and columnar cells in human colonic crypts. Am J Physiol Cell Physiol 278: C212–C233.
   PubMed Web of Science ®Google Scholar
• Hanauer S (1993): Medical therapy of ulcerative colitis. Lancet 342: 412–417.
   PubMed Web of Science ®Google Scholar
• Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkey GB (1992): Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: Cause, consequence or epiphenomenon? Pharmacol Ther 53: 375–408.
   PubMed Web of Science ®Google Scholar
• Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG (1995): The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 268: G673–G684.
   PubMed Web of Science ®Google Scholar
• Kaftan SM, Wright NA (1989): Studies on the mechanism of mucous cell depletion in ulcerative colitis. J Pathol 159: 75–85.
   PubMed Web of Science ®Google Scholar
• Kim HS, Berstad A (1992): The experimental colitis in animal models. Scand J Gastroenterol 27: 529–537.
   PubMed Web of Science ®Google Scholar
• Kim YS, Son MW, Ko JI, Cho HO, Yoo MH, Kim WB, Song IS, Kim CY (1999): Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease. Arch Pharm Res 22: 354–360.
   PubMed Web of Science ®Google Scholar
• María AOM, Repetto M, Llesuy S, Giordano O, Guzmán JA, Guerreiro E (2000): Antioxidant activity of extract and dehydroleucodine from Artemisia douglasiana. Besser. Phytother Res 14: 558–560.
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk ZMR, Wallace JL (1989): A hapten-induced model of chronic inflammation and ulceration in rat colon. Gastroenterology 96: 795–803.
   PubMed Web of Science ®Google Scholar
• Navarro V, Villareal M, Rojas G, Lozoya X (1996): Antimicrobial evaluation of some plants used in Mexican traditional medicine for the treatment of infectious diseases. J Ethnopharmacol 52: 143–147.
   Google Scholar
• Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996): Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nature Med 2: 998–1004.
   PubMed Web of Science ®Google Scholar
• Penissi AB, Fogal TH, Guzmán JA, Piezzi RS (1998): Gastroduodenal mucosal protection induced by dehydroleucodine. Mucus secretion and role of monoamines. Dig Dis Sci 43: 791–798.
   PubMed Web of Science ®Google Scholar
• Peterson TC, Davey K (1997): Effect of acute pentoxifylline in an experimental model of colitis. Aliment Pharmacol Ther 11: 575–580.
   PubMed Web of Science ®Google Scholar
• Pfeiffer CJ, Qiu BS (1995): Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmacol 47: 827–832.
   PubMed Web of Science ®Google Scholar
• Piezzi R, Guzmán J, Guardia T, Pestchanker M, Guerreiro O, Giordano O (1992): Dehydroleucodine prevents ethanol-induced necrosis in the rat gastric mucosa. A histological study. Micr Elect Biol Cel 16: 45–56.
   PubMedGoogle Scholar
• Podolsky DK (1991): Inflammatory bowel disease. N Engl J Med 325: 928–937.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Simon PL, Schwartz LW, Don Griswold E, Fondacaro JD, Wassermann MA (1989): Inflammatory mediators of experimental colitis in rats. Gastroenterology 97: 326–337.
   PubMed Web of Science ®Google Scholar
• Satoh H, Sato F, Takami K, Szabo S (1997): New ulcerative colitis model induced by sulphidryl blockers in rats and effects of antiinflammatory drugs on the colitis. Jpn J Pharmacol 73: 299–309.
   PubMedGoogle Scholar
• Wallace JL, Braquet P, Ibbotson GC, MacNaughton WK, Cirino G (1989): Assessment of the role of platelet activating factor in an animal model of inflammatory bowel disease. J Lipid Med 1: 13–23.
   PubMedGoogle Scholar
• Wallace JL, Higa A, Mc Knight GW, Mc Intyre DE (1992): Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence. Inflammation 16: 343–354.
   PubMed Web of Science ®Google Scholar
• Wendel GH, Bocco J, Bidinost C, Guzmán JA, Giordano O, Pelzer L (2002): Study of dehydroleucodine on their anti-inflammatory activity using the transcription factor NF-κB as target. Biocell 26: 403.
   Google Scholar
• Wendel GH, Maria AOM, Mohamed F, Domínguez S, Scardapane L, Giordano O, Guerreiro E, Guzmán JA (1999): Effect of dehydroleucodine in experimental olitis in rats and mice. Pharm Res 40: 339–344.
   Google Scholar
• Yamada Y, Marshall S, Specian RD, Grisham MB (1992): A comparative analysis of two models of colitis in rats. Gastroenterology 102: 1524–1534.
   PubMed Web of Science ®Google Scholar